Your session is about to expire
← Back to Search
Other
NAS babies for Neonatal Abstinence Syndrome (AA NAS Trial)
N/A
Waitlist Available
Led By Laura Weathers, MD
Research Sponsored by University of South Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group
Summary
This pilot study is intended to assess feasibility of auricular acupuncture in NAS infants who require pharmacologic therapy. We intend to evaluate acceptability of auricular acupuncture, infant tolerance, recruitment strategies, and methodological issues. We plan to also test and generate hypotheses in preparation to apply for funding a larger randomized controlled trial.
Eligible Conditions
- Neonatal Abstinence Syndrome
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Side effects data
From 2013 Phase 1 & 2 trial • 104 Patients • NCT013058112%
Serious unexpected
2%
Pain on needling
100%
80%
60%
40%
20%
0%
Study treatment Arm
Bi-Weekly Acupuncture
Wait List
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: NAS babiesExperimental Treatment1 Intervention
Acupuncture for NAS
Find a Location
Who is running the clinical trial?
University of South FloridaLead Sponsor
426 Previous Clinical Trials
191,818 Total Patients Enrolled
1 Trials studying Neonatal Abstinence Syndrome
26 Patients Enrolled for Neonatal Abstinence Syndrome
Laura Weathers, MDPrincipal InvestigatorUniversity of South Florida
Share this study with friends
Copy Link
Messenger